Ablation of CD8+ T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3
Srividhya Swaminathan(The University of Queensland), Corey Smith(QIMR Berghofer Medical Research Institute), Sweera Rehan(QIMR Berghofer Medical Research Institute), Lawton D. Murdolo(La Trobe University), Christopher Szeto(La Trobe University), Michael J. Dewar-Oldis(La Trobe University), Kirsty R. Short(The University of Queensland), Katie E. Lineburg(QIMR Berghofer Medical Research Institute), Peter J. Barnard(La Trobe University), Rajiv Khanna(QIMR Berghofer Medical Research Institute), Archana Panikkar(QIMR Berghofer Medical Research Institute), Michelle A. Neller(QIMR Berghofer Medical Research Institute), Stéphanie Gras(La Trobe University), Laëtitia Le Texier(QIMR Berghofer Medical Research Institute), Pauline Crooks(QIMR Berghofer Medical Research Institute), Jyothy Raju(QIMR Berghofer Medical Research Institute), George Ambalathingal(The University of Queensland)
Cited by 14
Related Papers
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
|Nature Medicine|2018|282
Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
|Frontiers in Cellular and Infection Microbiology|2018|282
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272
Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.
|Journal of Clinical Pathology|1984|261